Trial Profile
A Prospective, Randomized, Crossover Evaluation of the Effect of Atorvastatin on the Pharmacokinetics of Irinotecan in Colorectal Cancer Patients Receiving FOLFIRI
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer; Lipid metabolism disorders
- Focus Pharmacokinetics
- 29 May 2012 New trial record